Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

121. Ectopic pregnancy

Ectopic pregnancy Ectopic pregnancy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Ectopic pregnancy Last reviewed: August 2018 Last updated: January 2018 Summary Typically presents 6-8 weeks after last normal menstrual period, but can present earlier or later. Risk increases with prior ectopic pregnancy, tubal surgery, history of sexually transmitted infections, smoking, in vitro fertilisation, or if pregnant (...) of referred pain from intraperitoneal blood. Definition A fertilised ovum implanting and maturing outside of the uterine endometrial cavity, with the most common site being the fallopian tube (97%), followed by the ovary (3.2%) and the abdomen (1.3%). Bouyer J, Coste J, Fernandez H, et al. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002 Dec;17(12):3224-30. http://humrep.oxfordjournals.org/content/17/12/3224.full http://www.ncbi.nlm.nih.gov/pubmed/12456628?tool

BMJ Best Practice2018

122. Molar pregnancies

Molar pregnancies Molar pregnancies - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Molar pregnancies Last reviewed: August 2018 Last updated: March 2018 Summary Chromosomally abnormal pregnancies that have the potential to become malignant. Higher possibility of gestational trophoblastic disease (GTD) for women less than 20 years of age or over 35 years of age, and in those who have experienced GTD in a previous (...) pregnancy. Most common presenting symptom is vaginal bleeding. Suction dilation and evacuation (D&E) or hysterectomy are the preferred treatments. The risk of post-molar neoplasm is almost 20% for those with complete molar pregnancy. Rate of cure for post-molar gestational trophoblastic neoplasia exceeds 95%, often with preservation of fertility. Definition Hydatidiform moles are chromosomally abnormal pregnancies that have the potential to become malignant (gestational trophoblastic neoplasia

BMJ Best Practice2018

123. Nausea and vomiting in pregnancy

Nausea and vomiting in pregnancy Nausea and vomiting in pregnancy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Nausea and vomiting in pregnancy Last reviewed: August 2018 Last updated: March 2018 Summary Affects approximately 75% of pregnant women. Typically begins between the fourth and seventh week after the last menstrual period and resolves in the second trimester. Aetiology remains unclear. There is some (...) evidence that it is related to hormone levels of human chorionic gonadotrophin and oestrogen. Hyperemesis gravidarum represents the most severe form of nausea and vomiting of pregnancy. While there is lack of consensus of definition, most agree that clinical features include persistent vomiting, volume depletion, ketosis, electrolyte disturbances, and weight loss. Initial therapy should be conservative. This may include non-pharmacological treatments such as diet modification, emotional support, ginger

BMJ Best Practice2018

124. Assessment of abdominal pain in pregnancy

Assessment of abdominal pain in pregnancy Assessment of abdominal pain in pregnancy - Differential diagnosis of symptoms | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Assessment of abdominal pain in pregnancy Last reviewed: August 2018 Last updated: June 2018 Summary Abdominal pain throughout pregnancy is common. Many adaptive or physiological changes of pregnancy affect the presentation. Women tend to visit doctors often as they are concerned about (...) the health of their fetus. Patients require a careful assessment in order to reduce anxiety and give reassurance. If the clinical picture is unclear, a specialist should be consulted. Chamberlain G. ABC of antenatal care: abdominal pain in pregnancy. BMJ. 1991;302:390-1394. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1670063/pdf/bmj00129-0073.pdf http://www.ncbi.nlm.nih.gov/pubmed/2059722?tool=bestpractice.com Augustin G, Majerovic M. Non-obstetrical acute abdomen during pregnancy. Eur J Obstet Gynecol

BMJ Best Practice2018

125. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes

Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes 29222350 2017 12 09 1468-2060 2017 Dec 08 Annals of the rheumatic diseases Ann. Rheum. Dis. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes. annrheumdis-2017-212078 10.1136/annrheumdis-2017-212078 Leflunomide is known to be embryotoxic and teratogenic in rodents. However, there is less evidence in humans. We quantified the risk of major congenital malformation (MCM), prematurity, low (...) birth weight (LBW) and spontaneous abortion associated with leflunomide exposure during pregnancy in humans. From a cohort of 289 688 pregnancies in Montreal, Quebec, Canada, from 1998 to 2015, first-trimester leflunomide exposure and other antirheumatic drug exposures were studied for their association with MCM and spontaneous abortions. Also second or third-trimester leflunomide exposures were examined for associations with prematurity and LBW. Logistic regression model-based generalised estimating

EvidenceUpdates2018

126. Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study

Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study 29282333 2017 12 28 1526-632X 2017 Dec 27 Neurology Neurology Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study. 10.1212/WNL.0000000000004857 10.1212/WNL.0000000000004857 To assess the relative risk of oral clefts associated with maternal use of high and low doses of topiramate during the first trimester for epilepsy and nonepilepsy indications. This population-based (...) study nested in the US 2000-2010 Medicaid Analytic eXtract included a cohort of 1,360,101 pregnant women with a live-born infant enrolled in Medicaid from 3 months before conception through 1 month after delivery. Oral clefts were defined as the presence of a recorded diagnosis in claims during the first 90 days after birth. Women with a topiramate dispensing during the first trimester were compared with those without any dispensing and with an active reference group of women with a lamotrigine

EvidenceUpdates2018

127. Placental Complications Associated With Psychostimulant Use in Pregnancy

Placental Complications Associated With Psychostimulant Use in Pregnancy 29112657 2017 12 06 2017 12 19 1873-233X 130 6 2017 Dec Obstetrics and gynecology Obstet Gynecol Placental Complications Associated With Psychostimulant Use in Pregnancy. 1192-1201 10.1097/AOG.0000000000002362 To evaluate whether psychostimulants used to treat attention-deficit/hyperactivity disorder (ADHD) are associated with risk of adverse placental-associated pregnancy outcomes including preeclampsia, placental (...) abruption, growth restriction, and preterm birth. We designed a population-based cohort study in which we examined a cohort of pregnant women and their liveborn neonates enrolled in Medicaid from 2000 to 2010. Women who received amphetamine-dextroamphetamine or methylphenidate monotherapy in the first half of pregnancy were compared with unexposed women. We considered atomoxetine, a nonstimulant ADHD medication, as a negative control exposure. To assess whether the risk period extended to the latter

EvidenceUpdates2018

129. Women's and partners' experiences of pregnancy-, birth- and postnatal care. Results from a pilot study

Women's and partners' experiences of pregnancy-, birth- and postnatal care. Results from a pilot study Women's and partners' experiences of pregnancy-, birth- and postnatal care. Results from a pilot study - NIPH Selected items added to basket Close Vis søkefelt How can we help you today? Search for: Søk Menu • • Women's and partners' experiences of pregnancy-, birth- and postnatal care. Results from a pilot study Søk i Folkehelsa.no Search for: Søk Infectious diseases & Vaccines Close Mental (...) & Physical health Close Environment & Lifestyle Close Health in Norway Close Quality & Knowledge Close Research & Access to data Close Key message A Norwegian White Paper in 2009 emphasizes the importance of a broad user perspective in pregnancy-, birth- and postnatal care. The white paper calls for a national survey conducted by the Norwegian Knowledge Centre for the Health Services (NOKC) collecting user experience with this part of the health service. A national survey is planned in 2011- 2012. NOKC

The Norwegian Knowledge Centre for the Health Services2018

130. Canadian HIV Pregnancy Planning Guidelines

Canadian HIV Pregnancy Planning Guidelines DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Society of Obstetricians and Gynaecologists of Canada2018

132. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial.

Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial. Importance: Spontaneous preterm birth is a major cause of perinatal morbidity and mortality. It is unclear if a cervical pessary can reduce the risk of spontaneous preterm delivery. Objective: To test whether in asymptomatic women with singleton pregnancies and no prior spontaneous preterm birth but with short cervical length on transvaginal (...) of increased or new vaginal discharge (86.7% vs 46.0%; between-group difference, +40.7% [95% CI, +30.1%-+50.3%]; relative risk, 1.88 [95% CI, 1.57-2.27]). Conclusions and Relevance: Among women without prior spontaneous preterm birth who had asymptomatic singleton pregnancies and short transvaginal cervical length, use of a cervical pessary, compared with no pessary use, resulted in a lower rate of spontaneous preterm birth at less than 34 weeks of gestation. The results of this single-center, nonblinded

JAMA2017

133. A Data Model for Teleconsultation in Managing High-Risk Pregnancies: Design and Preliminary Evaluation

A Data Model for Teleconsultation in Managing High-Risk Pregnancies: Design and Preliminary Evaluation Appendix 1: Self-assessment checklist of specialists for teleconsultations Item No. Item description 1 The quality of patient-related data and information provided on this consultation is acceptable. 2 The volume of information presented in this consultation, to decide about the patient, is enough. 3 There is additional non-useful information in those provided about the patient. 4 Order

JMIR medical informatics2017 Full Text: Link to full Text with Trip Pro

135. Point-of-Care Urine Pregnancy Screening in the Emergency Department: Diagnostic Accuracy, Clinical Utility, and Guidelines

Point-of-Care Urine Pregnancy Screening in the Emergency Department: Diagnostic Accuracy, Clinical Utility, and Guidelines Point-of-Care Urine Pregnancy Screening in the Emergency Department: Diagnostic Accuracy, Clinical Utility, and Guidelines | CADTH.ca Find the information you need Point-of-Care Urine Pregnancy Screening in the Emergency Department: Diagnostic Accuracy, Clinical Utility, and Guidelines Point-of-Care Urine Pregnancy Screening in the Emergency Department: Diagnostic Accuracy (...) , Clinical Utility, and Guidelines Published on: December 7, 2017 Project Number: RB1173-000 Product Line: Research Type: Other Diagnostics Report Type: Summary of Abstracts Result type: Report Question What is the diagnostic accuracy of point-of-care urine pregnancy screens for patients presenting to the emergency department? What is the clinical utility of point-of-care urine pregnancy screens for patients presenting to the emergency department? What are the evidence-based guidelines associated

Canadian Agency for Drugs and Technologies in Health - Rapid Review2017

136. Valproic acid and pregnancy

Valproic acid and pregnancy Prescrire IN ENGLISH - Spotlight ''In the December issue of Prescrire International: valproic acid and pregnancy'', 1 December 2017 {1} {1} {1} | | > > > In the December issue of Prescrire International: valproic acid and pregnancy Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight In the December issue of Prescrire (...) International: valproic acid and pregnancy FREE DOWNLOAD A recently released study estimates that several thousand children in France who were exposed in utero to valproic acid or one of its derivatives between 1967 and 2016 were affected by at least one major congenital malformation. Full text available for free download. Summary In April 2017, the results of a French study of exposure to valproic acid or one of its derivatives (semisodium valproate and valpromide) during pregnancy and its consequences

Prescrire2017

137. Guidelines on autopsy practice: Fetal autopsy (2nd trimester fetal loss and termination of pregnancy for congenital anomaly)

Guidelines on autopsy practice: Fetal autopsy (2nd trimester fetal loss and termination of pregnancy for congenital anomaly) Guidelines on autopsy practice: Fetal autopsy (2nd trimester fetal loss and termination of pregnancy for congenital anomaly) " data-position="right" > Favourites OK In this section In this section In this section In this section In this section In this section In this section In this section In this section In this section In this section In this section In this section (...) In this section In this section In this section In this section In this section In this section In this section Guidelines on autopsy practice: Fetal autopsy (2nd trimester fetal loss and termination of pregnancy for congenital anomaly) Guidelines on autopsy practice: Fetal autopsy (2nd trimester fetal loss and termination of pregnancy for congenital anomaly) June 2017 June 2017 The Royal College of Pathologists 4th Floor, 21 Prescot Street London, E1 8BB Tel: +44 (0) 20 7451 6700 Email: ©2017 The Royal

Royal College of Pathologists2017

138. A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial

A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial 29016485 2017 11 02 2017 11 02 1873-233X 130 5 2017 Nov Obstetrics and gynecology Obstet Gynecol A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial. 1001-1010 10.1097/AOG.0000000000002267 To evaluate whether an intensive, medically supervised exercise intervention improved maternal glycemia and gestational weight gain in obese pregnant women when (...) in the control group and 11 in the intervention group did not complete the trial at 6 weeks postpartum (P=.61), but 43 in each group attended the 24- to 28-week glucose screen. There were no baseline maternal differences between groups. Classes commenced at a mean of 13 4/7±1 2/7 weeks of gestation. In early pregnancy, 51.1% (n=45/88) had an elevated fasting plasma glucose (92-125 mg/dL). There was no difference in the mean fasting plasma glucose at 24-28 weeks of gestation: 90.0±9.0 mg/dL (n=43) compared

EvidenceUpdates2017

139. Trends in Obstetric Intervention and Pregnancy Outcomes of Canadian Women With Diabetes in Pregnancy From 2004 to 2015

Trends in Obstetric Intervention and Pregnancy Outcomes of Canadian Women With Diabetes in Pregnancy From 2004 to 2015 ISSN 2472-1972 Trends in Obstetric Intervention and PregnancyOutcomesofCanadianWomen With Diabetes in Pregnancy From 2004 to 2015 Amy Metcalfe, 1,2,3 Yasser Sabr, 4,5 Jennifer A. Hutcheon, 4,6 Lois Donovan, 1,2 Janet Lyons, 4 Jason Burrows, 4 and K. S. Joseph 4,6 1 Departmentof Obstetrics and Gynecology, University ofCalgary,Calgary, AlbertaT2N2T9,Canada; 2 Department (...) andthehighestratesofadverseperinataloutcomesfollowedbywomenwithtype2diabetesmellitusand women with gestational diabetes mellitus. Rates of severe preeclampsia were 1.2% among women withoutdiabetesmellitus,2.1%amongwomenwithgestationaldiabetesmellitus,4.2%amongwomen withtype2diabetesmellitus,and7.5%amongwomenwithtype1diabetesmellitus(P,0.001).Therate ofneonatalmorbidityrangedfrom8.7%inwomenwithoutdiabetesmellitusto11.0%,17.4%,and24.1% in women with gestational, type 2, and type 1 diabetes mellitus, respectively (P, 0.001). Conclusions: In a contemporary obstetric population, women

Journal of the Endocrine Society2017 Full Text: Link to full Text with Trip Pro

140. Health Care Students’ Attitudes About Alcohol Consumption During Pregnancy: Responses to Narrative Vignettes

Health Care Students’ Attitudes About Alcohol Consumption During Pregnancy: Responses to Narrative Vignettes SAGE Journals: Your gateway to world-class journal research MENU Sign In Institution Society Access Options You can be signed in via any or all of the methods shown below at the same time. My Profile Sign in here to access free tools such as favourites and alerts, or to access personal subscriptions Email (required) Password (required) Remember me I don't have a profile I am signed

Global qualitative nursing research2017 Full Text: Link to full Text with Trip Pro